ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Double Negative T Cells Mediate Cd39-Dependent Protection in Hepatic Ischemia and Reperfusion Injury

H. Jin, M. Li, C. Zhang, G. Sun, D. Zhang

Beijing Key Laboratory of Tolerance Induction and Organ Protection in Transplantation, Beijing Friendship Hospital, Capital Medical University, Beijing, China

Meeting: 2021 American Transplant Congress

Abstract number: 303

Keywords: Immunosuppression, Ischemia, Neutrophils, T cells

Topic: Basic Science » Cellular Therapies, Tissue Engineering/Regenerative Medicine

Session Information

Session Name: Biomarkers and Cellular Therapies

Session Type: Rapid Fire Oral Abstract

Date: Tuesday, June 8, 2021

Session Time: 4:30pm-5:30pm

 Presentation Time: 4:40pm-4:45pm

Location: Virtual

*Purpose: Hepatic ischemia and reperfusion injury (HIRI) is a significant cause of morbidity and mortality following liver transplantation and major hepatic resections. Double negative T cells (DNT) are unique regulatory T cells which are discovered in recent decades.We have demonstrated that DNT significantly inhibit allo- or auto-immune responses mainly through perforin/granzyme B pathway. However, whether other mechanisms are involved in the immune regulation of DNT and the potential application of DNT in HIRI are still unknow.

*Methods: WT or CD39 deficient DNT were adoptively transferred before surgery, and then the mouse model of partial (70%) warm HIRI was established. In vitro, WT or CD39 deficient DNT were cocultured with neutrophils with or without ATP stimulation. Transcriptome sequencing of ATP treated WT or CD39 deficient DNT were analyzed.

*Results: In this study, we found DNT highly expressed CD39, a cell surface enzyme hydrolyzing extracellular ATP. Adoptively transferring with wild type (WT) but not CD39 deficient DNT significantly inhibited TNF-α and IL-1β secretion of liver infiltrated neutrophils, decreased neutrophil extracellular traps (NETs) generation and increased neutrophil apoptosis in warm HIRI in both C57BL/6 and T cell deficient B6.Rag2/IL2rc KO mice. Which contributed to markedly alleviated liver injury, as shown by lowered levels of serum ALT and reduced hepatocellular necrosis. Mechanistically, compared with WT DNT, CD39 deficient DNT were unable to hydrolyze extracellular cytotoxic ATP and became apoptotic under ATP stimulation. Transcriptome sequencing analysis suggested that ATP treated CD39 KO DNT had reduced expression of cell activation, proliferation and chemotaxis related genes than WT DNT. However, no differences of Prf1 or Gzmb gene expression were observed between groups. Furthermore, the level of extracellular immunosuppressive molecule, adenosine, was significantly higher in the culture of ATP treated WT DNT compared with that of CD39 deficient DNT. ATP-treated WT DNT but not CD39 deficient DNT significantly increased neutrophil apoptosis and inhibited inflammatory mediators secreted by neutrophils in vitro, suggesting that CD39 expressed by DNT might drive a shift from an ATP driven proinflammatory environment to an anti-inflammatory milieu induced by adenosine.

*Conclusions: In conclusion, our study reveals a new intrinsic mechanism that CD39 is crucial for DNT homeostasis and immunosuppressive function. These data support the concept and the feasibility of potentially utilizing this novel cell therapy for the prevention of HIRI during liver transplantation or hepatic surgery.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

Jin H, Li M, Zhang C, Sun G, Zhang D. Double Negative T Cells Mediate Cd39-Dependent Protection in Hepatic Ischemia and Reperfusion Injury [abstract]. Am J Transplant. 2021; 21 (suppl 3). https://atcmeetingabstracts.com/abstract/double-negative-t-cells-mediate-cd39-dependent-protection-in-hepatic-ischemia-and-reperfusion-injury/. Accessed May 16, 2025.

« Back to 2021 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences